Skip to main content

Table 2 Definitions of ELL for 50 US States and District of Columbia

From: More Guidelines than states: variations in U.S. lead screening and management guidance and impacts on shareable CDS development

ELL Definition (N = 51)States
No level specifieda (3)Arkansas [40], North Dakota [41], Wyoming [42]
Lead Level ≥ 3 μg/dL (1)New Hampshire [43, 44]
Lead Level ≥ 5 μg/dLb (37)Alabama [45], Alaska [46], Arizona [47, 48], California [49, 50], Colorado [51, 52], Connecticut [53, 54], District of Columbia [55, 56], Georgia [57,58,59], Hawaii [60, 61], Idaho [62, 63], Illinois [64, 65], Iowa [66, 67], Kentucky [68, 69], Louisiana [70,71,72], Maine [73, 74], Maryland [75], Massachusetts [76,77,78,79], Michigan [80, 81], Minnesota [82, 83], Mississippi [84, 85], Montana [86], Nebraska [87, 88], New Mexico [89], North Carolina [90], Ohio [91, 92], Oklahoma [93, 94], Oregon [95, 96], Pennsylvania [97], Rhode Island [98, 99], South Carolina [100], South Dakota [101, 102], Tennessee [103], Texas [104, 105], Vermont [106, 107], Virginia [108,109,110], Washington [111,112,113], Wisconsin [114, 115]
  1. aLead is included as a ‘reportable disease’ but no ELL threshold is defined and no other guidance is given
  2. bMontana does not provide screening guidance, but ELL is defined in the ‘reportable disease’ list when ≥5 μg/dL
  3. cNew York City defines ELL as ≥5 μg/dL, however the rest of New York State uses ELL as ≥10 μg/dL